GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
E

Egetis Therapeutics AB (publ) EGTX.ST · SEK

Health Care · Nasdaq Stockholm · 🇸🇪 Sweden

Compare

11.12

0.00%

Close of 9 Nov 2026, in SEK

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in SEK, from our data supplier.

FY2025

Revenue

SEK 62.4m

FY2016FY2025

Net income

−SEK 342.5m

FY2016FY2025

Free cash flow

−SEK 268.6m

FY2016FY2025

Shareholders' equity

SEK 338.7m

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueSEK 62.4mSEK 46.1mSEK 57.6mSEK 22.5mSEK 38.2mSEK 40.7mSEK 82.6mSEK 28.2mSEK 13.6m—
Research and developmentSEK 158.3mSEK 146.2mSEK 194.0mSEK 136.3mSEK 88.7mSEK 183.3mSEK 112.2mSEK 83.9mSEK 74.2mSEK 19.5m
Operating income−SEK 346.9m−SEK 333.8m−SEK 324.7m−SEK 198.1m−SEK 105.7m−SEK 178.4m−SEK 66.7m−SEK 92.5m−SEK 88.1m−SEK 38.4m
Net income−SEK 342.5m−SEK 343.6m−SEK 326.9m−SEK 189.5m−SEK 104.7m−SEK 179.1m−SEK 61.4m−SEK 85.0m−SEK 87.9m−SEK 38.2m
Diluted earnings per share-0.87-0.98-1.13-0.88-0.63-3.30-1.13-1.72-1.78-1.33

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsSEK 639.1mSEK 792.3mSEK 760.2mSEK 561.1mSEK 569.3mSEK 894.0mSEK 270.1mSEK 242.0mSEK 315.4mSEK 396.4m
Cash and short-term investmentsSEK 215.8mSEK 351.0mSEK 303.3mSEK 127.7mSEK 144.0mSEK 287.9mSEK 255.1mSEK 229.9mSEK 309.5mSEK 394.0m
Total liabilitiesSEK 300.4mSEK 299.4mSEK 214.6mSEK 54.9mSEK 42.2mSEK 264.3mSEK 25.2mSEK 22.7mSEK 11.7mSEK 6.9m
DebtSEK 90.6mSEK 117.4mSEK 113.0mSEK 2.7mSEK 4.2mSEK 4.7mSEK 117,000———
Shareholders' equitySEK 338.7mSEK 492.8mSEK 545.6mSEK 506.2mSEK 527.0mSEK 629.6mSEK 244.9mSEK 219.4mSEK 303.7mSEK 389.6m
Shares outstanding395m351m290m215m165m54m54m49m49m29m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations−SEK 267.1m−SEK 227.9m−SEK 278.4m−SEK 173.5m−SEK 130.1m−SEK 134.6m−SEK 62.6m−SEK 80.3m−SEK 86.6m−SEK 36.1m
Capital spending−SEK 1.5m———−SEK 172,000−SEK 24,000−SEK 24,000−SEK 24,000−SEK 24,000—
Free cash flow−SEK 268.6m−SEK 227.9m−SEK 278.4m−SEK 173.5m−SEK 130.3m−SEK 134.7m−SEK 62.7m−SEK 80.3m−SEK 86.6m−SEK 36.1m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueSEK 17.4mSEK 13.4mSEK 17.9mSEK 17.4mSEK 14.5mSEK 12.7mSEK 10.8mSEK 9.4m
Operating income−SEK 106.5m−SEK 90.8m−SEK 124.1m−SEK 79.3m−SEK 78.5m−SEK 64.7m−SEK 104.7m−SEK 82.7m
Net income−SEK 108.9m−SEK 94.5m−SEK 119.7m−SEK 82.4m−SEK 77.6m−SEK 62.9m−SEK 110.5m−SEK 86.2m
Diluted earnings per share-0.24-0.21-0.30-0.21-0.20-0.16-0.31-0.25
Cash from operations−SEK 94.0m−SEK 64.0m−SEK 92.0m−SEK 49.0m−SEK 59.0m−SEK 66.0m−SEK 53.0m−SEK 62.0m
Capital spending−SEK 1.0m———−SEK 1.0m———
Free cash flow−SEK 95.0m———−SEK 60.0m———
Total assetsSEK 760.5mSEK 537.4mSEK 639.1mSEK 595.1mSEK 654.4mSEK 724.1mSEK 792.3mSEK 577.5m
Cash and short-term investmentsSEK 378.4mSEK 142.5mSEK 215.8mSEK 145.7mSEK 202.6mSEK 272.8mSEK 351.0mSEK 129.9m
DebtSEK 64.7mSEK 70.3mSEK 76.5mSEK 85.7mSEK 89.7mSEK 98.7mSEK 114.2mSEK 111.2m
Shareholders' equitySEK 481.5mSEK 248.6mSEK 338.7mSEK 277.4mSEK 355.0mSEK 433.3mSEK 492.8mSEK 318.6m

Financial ratios

Data as of 31 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Operating margin-555.9%-688.3%-560.2%-860.9%-272.9%-437.8%———
Net margin-548.9%-745.3%-567.5%-842.2%-273.9%-440.5%———
Return on equity-101.1%-69.7%-59.9%-37.4%-19.9%-28.4%———
Return on assets-53.6%-43.4%-43.0%-33.8%-18.4%-20.0%———
Free cash flow yield-6.7%———-7.8%-24.6%-11.5%-16.2%-17.4%
Revenue growth35.4%-20.0%156.0%-41.2%-5.9%-50.7%———
Earnings growth-0.3%5.1%72.5%80.9%-41.5%191.6%———
Current ratio1.05x1.86x3.33x2.98x3.90x4.28x———
Debt to equity0.25x0.24x0.20x0.00x0.00x-0.06x———
Equity ratio53.0%62.2%71.8%90.2%92.6%70.4%———
Interest coverage-15.28x-12.25x-78.71x-1937.00x-521.77x-178023.00x———
R&D as a share of sales253.7%317.1%336.8%605.8%231.9%450.7%———
Buybacks as a share of market value-12.5%-21.0%-35.2%-30.0%-203.9%0.0%———

Growth per year

Compound annual rate

3 years5 years10 years
Revenue40.5%8.9%—
Operating income20.5%14.2%22.9%
Net income21.8%13.8%22.8%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin-627.4%-638.1%-556.1%—
Net margin-632.4%-637.6%-555.6%—

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings-6.2-7.2-5.0-8.0-9.7-2.1-10.3-5.2-6.0-7.7
Price to sales33.853.328.167.726.69.27.715.538.7—

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.